International Stem Cell CORP [ISCO] has reported $7.8 million in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $131.0 thousand.
Based in Carlsbad, California, International Stem Cell CORP operates in the Manufacturing sector.